When organizations collaborate, sponsors can leverage unique expertise, unparalleled resources, and an established, stable infrastructure, including research, sites, donors, partnerships, and scientific and operational expertise.
Patients should have access to their medical records and be able to move from one treatment center to another and to obtain access to trials.
Effective change management systems ensure that innovation and continual improvement are facilitated, that change is appropriate and proportionate, and that key personnel take a level of ownership of the change.
Frankly, the clinical research enterprise needs advocates and, more pointedly, it needs us to advocate for why ours is a true profession.
Strategic end-to-end drug development, a lesser-known component of the R&D process that occurs in parallel with clinical trials, represents a major opportunity for pharma to recoup costs and find critical time efficiencies.